Trial Profile
Ancillary study of rosuvastatin versus placebo for sepsis-associated adult respiratory distress syndrome.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Aug 2015
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Adult respiratory distress syndrome
- Focus Therapeutic Use
- 17 Aug 2015 New trial record